Zobrazeno 1 - 10
of 251
pro vyhledávání: '"M Onsrud"'
Autor:
E. Kleppa, V. Ramsuran, S. Zulu, G.H. Karlsen, P. Ndhlovu, K. Lillebø, S.D. Holmen, M. Onsrud, S.G. Gundersen, M. Taylor, E.F. Kjetland, T. Ndung’u
Publikováno v:
International Journal of Infectious Diseases, Vol 21, Iss S1, p 60 (2014)
Externí odkaz:
https://doaj.org/article/e611efa6e977472dbbaf00a16dd74608
Autor:
S.D. Holmen, M. Onsrud, B.J. Vennervald, F. Albregtsen, M. Taylor, J. Moodley, L. van Lieshout, P. Pillay, K. Lillebø, E. Kleppa, E.F. Kjetland
Publikováno v:
International Journal of Infectious Diseases, Vol 21, Iss S1, p 169 (2014)
Externí odkaz:
https://doaj.org/article/b6d5cbfe7d2949bbb754647a5b687fb0
Publikováno v:
Acta Pathologica Microbiologica Scandinavica Series C: Immunology. :271-276
The effects of in vivo diethylstilbosterol phosphate (DES-P) on lymphoid cells were studied in six patients with adenocarcinoma of the prostate. The administration of 500 mg DES-P intravenously caused increased numbers of circulating granulocytes, mo
Autor:
Jan Delabie, R. Rimala, Björn Risberg, M. Onsrud, A. K. Lie, B. Borge, S. Thoresen, B. Sandstad
Publikováno v:
Gynecologic Oncology. 97:908-915
Objective. To compare DNA-based and mRNA-based methods for detection of high-grade cervical neoplasia in Norway. Methods. HPV prevalence was analyzed in 383 women with positive index cytology, selected from gynecology clinics. All patients were inves
Autor:
Elke Lorenz, A. Himmelmann, M. Onsrud, K. Kjørstad, G. Gundersen, B. Hagen, Solveig Tingulstad
Publikováno v:
International Journal of Gynecological Cancer. 9:373-376
Lorenz E, Hagen B, Himmelmann A, Kjorstad K, Onsrud M, Tingelstad S, Gundersen G. A phase II study of biweekly administration of paclitaxel in patients with recurrent epithelial ovarian cancer. The purpose of this study was to assess the efficacy and
Publikováno v:
International Journal of Gynecological Cancer. 9:110-116
The purpose of the study was to explore the combination of thio-TEPA with cisplatin in first-line chemotherapy of epithelial ovarian cancer with special reference to pharmacokinetic and pharmacodynamic relationships. Ten women with advanced disease w
Autor:
K. Bertelsen, K. Boman, Bente Lund, Claes G. Tropé, M. Onsrud, T. Kuoppola, Thomas Högberg, Gábor Horváth, J. Vartianen, Janne Kærn, E. Simonsen, M. Scheistroen, Ulla Puistola, T. Salmi, A. Himmelmann, Bengt Sorbe, A. Jacobsen, E. Bjorkholm, Bengt Tholander, R. Westberg, Roar Sandvei
Publikováno v:
Annals of Oncology. 9:1301-1307
BACKGROUND: Owing to the wide spread perception of a possible benefit from paclitaxel in the second-line situation the Nordic Gynecologic Oncology Group (NGOG) conducted two prospective phase II studies of paclitaxel single agent treatment (175 mg/m2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ernst Simonsen, Kolbein Sundfør, M. Onsrud, Claes G. Tropé, K Bertelsen, J Koern, R. Westberg, Thomas Högberg
Publikováno v:
Cancer. 77:2371-2378
BACKGROUND: The locoregional failure rate remains high in advanced cervical carcinoma. Chemotherapy (CT) was added to radiotherapy (RT) in order to increase disease control and to improve 5-year survival.METHODS: CT + RT included cisplatin administer
Autor:
J. Leeser, M. Rust, Gnc Kenny, P. Saur, David J. Rowbotham, M. Onsrud, H. Lip, J.D.L. Oates, C.G. Haigh
Publikováno v:
British Journal of Anaesthesia. 68:466-470
In a placebo-controlled, double-blind study, we have compared the efficacy of ondansetron 16 mg, 8 mg and 1 mg administered 8-hourly for prevention of postoperative nausea and vomiting. We studied 995 patients undergoing major gynaecological surgery;